IRCT2016090729747N1已完成1 期
Evaluating the Safety and Effect of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cell Transplantation on Development of Renal Function Indexes in Patients with Severe and Refractory Lupus Nephritis in Comparison to the Standard Treatment Protocol
Council for Stem Cell Sciences and Technologies0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Criteria for entrance to the study: Criteria for entrance to the study include increase in proteinuria (defined as more than 1.0 g of protein excretion in a 24-h urine specimen), Systemic lupus erythematosus disease activity index of more than 8 (All patients were resistant to at least 3 months of therapy with conventional treatment standard).
- •Exclusion criteria:
- •uncontrolled infection, failure of kidney or other vital organs, pregnancy or lactating.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Safety and efficacy of Mesenchymal Stem Cell administration in Bronchiolitis Obliterans Syndrome.IRCT20201202049568N2Tehran University of Medical Sciences10
招募中
1 期
Application of Cord Blood Platelet Gel (CBPG) for the treatment of non-healing skin ulcers due to the cutaneous chronic GVHDIRCT20190101042197N1Royan Stem cell Technology Co.15
招募中
2 期
Effect of treatmen with natural killer cells in acute myeloid leukemiaAcute myeloblastic leukemiaAcute Myeloid leukemia.C92.0IRCT20200417047113N2Middle East Gene Therapy corporation5
招募中
1 期
Effect of NK cell therapy in COVID-19IRCT20200417047113N1Middle East Gene Therapy corporation70
已完成
1 期
Evaluation of the safety and efficacy of allogenic hematopoietic stem cell transplantation (HSCT) from HLA-mismatched related donors using alemtuzumab in patients with hematological malignancies.Hematological malignanciesJPRN-C000000357GCP-ISS HE0402 group48